Cancer3.AI › News

News

Curated oncology headlines from reputable sources, ranked by importance with Claude Opus 4.7.

★ 5.5 Cancer Cell
2026-02-26

Overcoming functional and translational challenges of cellular immunotherapies for solid tumors

A comprehensive review published in Cancer Cell by Chen et al. examines the major barriers preventing cellular immunotherapies — including CAR-T and other engineered cell-based treatments — from replicating their success in blood cancers when applied to solid tumors. The authors systematically assess functional impediments such as the immunosuppressive tumor microenvironment, antigen heterogeneity…

Read the full story → Open original ↗
★ 5.5 Cell
2026-04-16

Hallmarks of liver cancer: Therapeutic implications

A comprehensive review published in Cell examines the distinct cancer hallmarks driving hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA), the two major forms of primary liver cancer. The authors detail how these hallmarks shape each tumor's biology, therapeutic vulnerabilities, and interactions with the immune microenvironment. The work synthesizes current knowledge on how…

Read the full story → Open original ↗
★ 5.5 Cell
2026-04-16

Cancer ecosystems: A dynamic interplay across scales

A landmark review published in Cell by Quail and Joyce proposes a multi-scale framework for understanding cancer as a complex ecosystem rather than a collection of malignant cells acting in isolation. The authors describe how diverse cell populations within the tumor microenvironment form specialized niches that are continuously reshaped by systemic physiology, environmental factors, and treatment…

Read the full story → Open original ↗
★ 5.5 Cell
2026-04-16

Mapping intratumor heterogeneity across layers for advancing immunotherapy

A comprehensive review published in Cell examines how multi-layer intratumor heterogeneity — the diversity of cell populations, genomic profiles, and microenvironmental features within a single tumor — shapes immune responses and treatment outcomes across cancer types. The authors argue that integrating data from multiple biological layers, rather than analyzing them in isolation, is essential for…

Read the full story → Open original ↗
★ 5.5 Cell
2026-04-16

Targeting angiogenesis: Lessons from 25 years of normalizing tumor vasculature

A major review published in Cell synthesizes 25 years of research on anti-angiogenic cancer therapy, tracing the field's evolution from the original concept of starving tumors by blocking blood vessel growth to the more nuanced strategy of vascular normalization. The authors highlight how spatial-omics technologies are providing unprecedented insights into the architecture and heterogeneity of tum…

Read the full story → Open original ↗
★ 5.5 Cell
2026-04-03

Senescence in cancer: Hallmarks, paradoxes, and therapeutic promise

A major review published in Cell presents a unified framework for understanding cellular senescence in cancer, defining six hallmark features of the senescent state. The authors describe how senescence simultaneously halts cell division yet rewires chromatin architecture, metabolism, microenvironment sensing, and immune interactions in ways that can either suppress or paradoxically promote tumor g…

Read the full story → Open original ↗
★ 5.5 Cell
2026-04-16

Targeting genomic instability in cancer

A comprehensive review published in Cell examines the evolving landscape of therapies targeting genomic instability, a fundamental hallmark of cancer. The article traces the therapeutic arc from traditional chemotherapy and radiation through PARP inhibitors for DNA-repair-deficient tumors to newer modalities such as antibody-drug conjugates and radiopharmaceuticals. The authors highlight how preci…

Read the full story → Open original ↗
★ 5.5 Nature Reviews Clinical Oncology
2026-04-13

Multidisciplinary management of meningiomas in the era of precision oncology

A comprehensive review published in Nature Reviews Clinical Oncology presents an integrated roadmap for managing meningiomas — the most common primary intracranial tumors — incorporating advances in precision oncology. The authors highlight that while surgery and radiotherapy have long been the standard approach, the past decade has yielded promising novel treatment options driven by molecular ins…

Read the full story → Open original ↗
★ 5.5 Nature Reviews Cancer
2026-04-10

Kill three birds with one stone

A study by Gudenas and colleagues, highlighted in Nature Reviews Cancer, has mapped the developmental origins of pineoblastoma subgroups to specific pinealocyte progenitor cells. The researchers discovered a shared photoreceptor-like transcriptional network that is active across three distinct pediatric malignancies: pineoblastoma, retinoblastoma, and group 3 medulloblastoma. This convergence on a…

Read the full story → Open original ↗
★ 5.5 Nature Reviews Cancer
2026-04-14

The versatile interplay between steatotic liver disease and liver cancer

A comprehensive review published in Nature Reviews Cancer examines how metabolic dysfunction-associated steatotic liver disease (MASLD) and alcoholic liver disease (ALD) drive the development of liver cancer through chronic liver injury and sustained inflammation. Rahbari and colleagues detail the distinct pathophysiological mechanisms by which each condition promotes hepatic carcinogenesis, highl…

Read the full story → Open original ↗